523 research outputs found
Recherche et caractérisation de sols résistants aux Pythium spp. en Amazonie brésilienne
Aux environs de la ville de Manaus (Amazonie brésilienne), les sols sont localisés dans deux écosystèmes: ‘terra firme’ recouverte de foret vierge ou cultivée et ‘varzea’, zones submergées chaque année et cultivées. 160 échantillons de sol ont été prélevés dans ccs deux zones, puis analysés afin de déterminer leur capacité de fonte des semis, causée par les Pythium spp.; 76 de ces sols semblaient non infestés, ou ne l'étaient que faiblement. Afin de déterminer leur réceptivité vis‐à‐vis des Pythium spp., les 76 sols ont été inoculés avec 10% d'un sol infesté naturellement, et la capacité d'infection a étéévaluée aprés des incubations de 4, 8, 12 et 16 semaines par tests biologiques sur jeunes plants de concombre. L'aptitude à supprimer les Pythium spp. n'est apparue que dans les écosystèmes ‘terra firme'et non dans les ‘varzeas’ submergés. La fréquence des sols pouvant supprimer la maladie semblait décroitre en fonction de la mise en culture: 82% dans les sols de foret vierge; 67% dans les sols de pépinières forestiéres; 53% dans les forets gérées; 31% dans les sols forestiers mis en culture avec des cultures variées; 7% dans les sols forestiers mis en culture et portant des cultures maraichères. On a constaté trois types d'aptitude à supprimer les Pythium spp. aprés inoculation des sols: (1) résistance apparaissant rapidement et se maintenant à un niveau élevé et constant (jusqu'à 16 semaines); (2) résistance initiate élevée, mais non durable; (3) résistance initialement faible, mais croissante avec le temps. Une partie de cette dynamique semble etre sous controle microbien. Le développement agricole autour de Manaus ainsi que les systèmes de culture intensifs peuvent rapidement modifier les écosystèmes microbiens des sols et nuire à leur capacité naturelle à supprimer les Pythium spp. Copyright © 1987, Wiley Blackwell. All rights reserve
Surveying activated sludge changes during acclimation with artificial wastewater
Many processes in the chemical and pharmaceutical industries generate wastewater containing organic
toxic compounds and other kinds of xenobiotics. Usually, biological treatments are used to degrade a
great quantity of these substances. However, most of the time, the microorganisms are not adapted and
the treatment can be blocked. Therefore, the first step to make a continuous reactor operative is the
acclimation, i.e., the adaptation of the microorganisms to a specific substrate. During this particular step
of the process there is a selection and a multiplication of specialized microorganisms and physiological
transformations can occur in their metabolic system. Furthermore, combining image processing
techniques have already been successfully used to elucidate the activated sludge morphological changes
for both aggregated and filamentous bacteria contents, during such processes.
The experimental set-up is composed of an aerated reactor and a clarifier. The sludge is recycled from the
clarifier by a peristaltic pump. The complete mixing inside the reactor is guaranteed by the diffusion of
air from its bottom. The reactor was inoculated with biomass collected from a wastewater treatment plant
and fed with an artificial wastewater based on meat extract. During acclimation, chemical parameters
were measured in the influent, reactor and effluent, in order to verify the stability of the process. To
complete the evaluation of the process, microscopy acquisition and image processing and analysis
techniques were performed for aggregates and filamentous bacteria characterization for bright field, Gram
and poly-β-hydroxybutyrate (PHB) staining images. The information extracted from those images
allowed for aggregates and filamentous bacteria contents inspection, identification of PHB storing
microorganisms and, gram-positive and gram-negative filamentous bacteria recognition. Figure 1 presents
activated sludge samples at the beginning and at the end of the acclimation phase. It was found in this
study that biomass changes during the acclimation phase could be effectively monitored, combining
image analysis information and chemical parameters
The W43-MM1 mini-starburst ridge, a test for star formation efficiency models
Context: Star formation efficiency (SFE) theories are currently based on
statistical distributions of turbulent cloud structures and a simple model of
star formation from cores. They remain poorly tested, especially at the highest
densities. Aims: We investigate the effects of gas density on the SFE through
measurements of the core formation efficiency (CFE). With a total mass of
M, the W43-MM1 ridge is one of the most convincing
candidate precursor of starburst clusters and thus one of the best place to
investigate star formation. Methods: We used high-angular resolution maps
obtained at 3 mm and 1 mm within W43-MM1 with the IRAM Plateau de Bure
Interferometer to reveal a cluster of 11 massive dense cores (MDCs), and, one
of the most massive protostellar cores known. An Herschel column density image
provided the mass distribution of the cloud gas. We then measured the
'instantaneous' CFE and estimated the SFE and the star formation rate (SFR)
within subregions of the W43-MM1 ridge. Results: The high SFE found in the
ridge (6% enclosed in 8 pc) confirms its ability to form a
starburst cluster. There is however a clear lack of dense cores in the northern
part of the ridge, which may be currently assembling. The CFE and the SFE are
observed to increase with volume gas density while the SFR steeply decreases
with the virial parameter, . Statistical models of the SFR may
well describe the outskirts of the W43-MM1 ridge but struggle to reproduce its
inner part, which corresponds to measurements at low . It may be
that ridges do not follow the log-normal density distribution, Larson
relations, and stationary conditions forced in the statistical SFR models.Comment: 13 pages, 7 figures. Accepted by A&
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA
Background & Aims
Infections are common in patients with severe alcoholic hepatitis (SAH), but little information is available on how to predict their development or their effects on patients. Prednisolone is advocated for treatment of SAH, but can increase susceptibility to infection. We compared the effects of infection on clinical outcomes of patients treated with and without prednisolone, and identified risk factors for development of infection in SAH.
Methods
We analyzed data from 1092 patients enrolled in a double-blind placebo-controlled trial to evaluate the efficacy of treatment with prednisolone (40 mg daily) or pentoxifylline (400 mg 3 times each day) in patients with SAH. The 2 × 2 factorial design led to 547 patients receiving prednisolone; 546 were treated with pentoxifylline. The trial was conducted in the United Kingdom from January 2011 through February 2014. Data on development of infection were collected at evaluations performed at screening, baseline, weekly during admission, on discharge, and after 90 days. Patients were diagnosed with infection based on published clinical and microbiologic criteria. Risk factors for development of infection and effects on 90-day mortality were evaluated separately in patients treated with prednisolone (n = 547) and patients not treated with prednisolone (n = 545) using logistic regression. Pretreatment blood levels of bacterial DNA (bDNA) were measured in 731 patients.
Results
Of the 1092 patients in the study, 135 had an infection at baseline, 251 developed infections during treatment, and 89 patients developed an infection after treatment. There was no association between pentoxifylline therapy and the risk of serious infection (P = .084), infection during treatment (P = .20), or infection after treatment (P = .27). Infections classified as serious were more frequent in patients treated with prednisolone (odds ratio [OR], 1.27; 95% confidence interval [CI], 1.27−2.92; P = .002). There was no association between prednisolone therapy and infection during treatment (OR, 1.04; 95% CI, 0.78−1.37; P = .80). However, a higher proportion (10%) of patients receiving prednisolone developed an infection after treatment than of patients not given prednisolone (6%) (OR, 1.70; 95% CI, 1.07−2.69; P = .024). Development of infection was associated with increased 90-day mortality in patients with SAH treated with prednisolone, independent of model for end-stage liver disease or Lille score (OR, 2.46; 95% CI, 1.41−4.30; P = .002). High circulating bDNA predicted infection that developed within 7 days of prednisolone therapy, independent of Model for End-Stage Liver Disease and white blood cell count (OR, 4.68; 95% CI, 1.80−12.17; P = .001). In patients who did not receive prednisolone, infection was not independently associated with 90-day mortality (OR, 0.94; 95% CI, 0.54−1.62; P = .82) or levels of bDNA (OR, 0.83; 95% CI, 0.39−1.75; P = .62).
Conclusions
Patients with SAH given prednisolone are at greater risk for developing serious infections and infections after treatment than patients not given prednisolone, which may offset its therapeutic benefit. Level of circulating bDNA before treatment could identify patients at high risk of infection if given prednisolone; these data could be used to select therapies for patients with SAH. EudraCT no: 2009-013897-42; Current Controlled Trials no: ISRCTN88782125
Embryonic development of pleuropodia of the cicada, Magicicada cassini
In many insects the first abdominal segment possesses embryonic appendages called pleuropodia. Here we show the embryogenesis of pleuropodial cells of the periodical cicada, Magicicada cassini (Fisher 1851) (Insecta, Homoptera, Cicadidae). An antibody, anti-horseradish perioxidase (HRP), that is usually neuron-specific strongly marked the pleuropodial anlagen and revealed their ectodermal origin shortly after limb bud formation. Thereafter the cells sank into the epidermis and their apical parts enlarged. A globular part protruded from the body wall. Filamentous structures were marked at the stem region and into the apical dilation. In later embryonic stages the pleuropodia degenerated. Despite the binding of anti-HRP the cells had no morphological neuronal characters and cannot be regarded as neurons. The binding indicates that glycosylated cell surface molecules contribute to the adhesion between the presumably glandular pleuropodial cells. In comparison, anti-HRP does not mark the pleuropodia of Orthoptera
To buy or not to buy-evaluating commercial AI solutions in radiology (the ECLAIR guidelines).
Artificial intelligence (AI) has made impressive progress over the past few years, including many applications in medical imaging. Numerous commercial solutions based on AI techniques are now available for sale, forcing radiology practices to learn how to properly assess these tools. While several guidelines describing good practices for conducting and reporting AI-based research in medicine and radiology have been published, fewer efforts have focused on recommendations addressing the key questions to consider when critically assessing AI solutions before purchase. Commercial AI solutions are typically complicated software products, for the evaluation of which many factors are to be considered. In this work, authors from academia and industry have joined efforts to propose a practical framework that will help stakeholders evaluate commercial AI solutions in radiology (the ECLAIR guidelines) and reach an informed decision. Topics to consider in the evaluation include the relevance of the solution from the point of view of each stakeholder, issues regarding performance and validation, usability and integration, regulatory and legal aspects, and financial and support services. KEY POINTS: • Numerous commercial solutions based on artificial intelligence techniques are now available for sale, and radiology practices have to learn how to properly assess these tools. • We propose a framework focusing on practical points to consider when assessing an AI solution in medical imaging, allowing all stakeholders to conduct relevant discussions with manufacturers and reach an informed decision as to whether to purchase an AI commercial solution for imaging applications. • Topics to consider in the evaluation include the relevance of the solution from the point of view of each stakeholder, issues regarding performance and validation, usability and integration, regulatory and legal aspects, and financial and support services
A bayesian meta-analysis of multiple treatment comparisons of systemic regimens for advanced pancreatic cancer
© 2014 Chan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Background: For advanced pancreatic cancer, many regimens have been compared with gemcitabine (G) as the standard arm in randomized controlled trials. Few regimens have been directly compared with each other in randomized controlled trials and the relative efficacy and safety among them remains unclear
Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue.
Acute decompensation and death have been observed in patients with acute hepatitis E virus (HEV) infection and preexisting liver cirrhosis. However, the clinical, laboratory and histological features need to be fully characterised.
Some of us recently described the histological presentation of hepatitis E in a large panel of liver tissue specimens. Here, we conducted a case-control study to investigate the clinical and laboratory features of the subset of patients with HEV-related acute-on-chronic liver failure (ACLF) and death. Each patient was matched to three control patients with histologically confirmed severe alcoholic hepatitis based on sex, age, total bilirubin, INR, serum creatinine and MELD score on admission.
Of 5 patients who died in a context of HEV-related ACLF, 3 (60%) were male and the median age was 66 years (range 51–76). Median alanine aminotransferase (ALT) at presentation was 2610 U/l (range 705–3134) and aspartate aminotransferase (AST) 2818 U/l (range 1176–8611). Liver function was heavily altered in all patients. Histological analyses revealed steatohepatitis on a background of cirrhosis, suggestive of an alcoholic or nonalcoholic origin. Based on histopathology, alcoholic hepatitis was initially suspected in two patients and corticosteroid treatment was initiated. Ribavirin was started in four patients. Median time from hospitalisation to death was 17 days (range 6–25 days). AST levels in patients with HEV-related ACLF were significantly higher as compared to the matched patients with severe alcoholic hepatitis.
Typical histopathological features of viral hepatitis may be absent in ACLF caused by HEV infection. HEV infection should be sought in acute decompensation of cirrhosis and ACLF even in the absence of histological changes suggesting viral infection
- …